Obsessive-Compulsive & Related Disorders Update 2021

PSYCHIATRY EDUCATION FORUM'S
THIRD ONLINE CONFERENCE:

OBSESSIVE-COMPULSIVE & RELATED DISORDERS
UPDATE 2021

CONFERENCE RELEASE DATE: AUG 1, 2021

Our third conference focuses exclusively on one of the most important aspects of your practice:

Learn Directly from the Experts in this Field on How to Manage Various Aspects of Obsessive-Compulsive and Related Disorders

Welcome

Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to improve your clinical decision-making. In this third conference, we have only invited the experts in the field of obsessive-compulsive & related disorders and once again published this conference with no sponsors or influence from pharmaceutical companies.  

We guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.

WATCH INTRODUCTION VIDEO:

CONFERENCE FEATURES

LEARN FROM EXPERTS

All lectures in this conferences are from the experts in the field of Obsessive-Compulsive & Related Disorders.

NO SPONSORS

No pharmaceutical or non-pharmaceutical sponsors. All lectures are based on clinical data from literature with no influence from sponsors.

ONLINE CONFERENCE

Finish this conference at your own pace, and at any time with no need to spend money on travel-related expenses.

cme credits & pEER REVIEWED

This conference is peer reiewed and will offer a maximum of 5.25 AMA PRA Category 1 Credits™. (see details below for more details)

CONFERENCE SCHEDULE

This conference contains the following lectures by experts in the field of obsessive-compulsive & related disorders, and they are divided in following two sections based on the availability of CME credits for each educational activity: (a) CME-Accredited program and (b) Non-Accredited program.

(A) CME-ACCREDITED PROGRAM

(1) OCD PSYCHOPHARMACOLOGY UPDATE 2021

Pharmacotherapy for OCD: 2021 Algorithm
(Psychopharmacology Algorithm Project)

(Session Duration: 1 hour)

  • Evidence-informed recommendations for OCD treatment considering efficacy, tolerability, safety, & patient preference.
  • Initial medications of choice for OCD treatment. 
  • Next treatment options depending on (a) good response, (b) partial response, & (c) poor response to first-line and second-line treatment.
  • Augmentation options.
  • Novel agents for OCD treatment.
  • Non-invasive device-based approaches & neurosurgery options. 
David Osser, MD

Associate Professor of Psychiatry at Harvard Medical School & Editor of Psychopharmacology Algorithm Project.

(2) TREATMENT-REFRACTORY PEDIATRIC OCD

Management of Treatment-Refractory
Pediatric OCD

(Session Duration: 1 hour)

  • Pediatric OCD: diagnosis, characteristic & OCD Symptoms sub-types.
  • Adult OCD versus pediatric OCD
  • Severity measurement tools for pediatric OCD
  • Defining treatment response, remission, recovery, relapse, treatment-refractory, treatment-intolerant pediatric OCD.
  • Reviewing landmark pediatric OCD studies.
  • Moderators of treatment response in pediatric OCD.
  • Tic-related OCD
  • Medications Dosing guidelines for pre-adolescent and adolescent OCD.
  • Medications: understanding safety risk including the risk of suicidal ideations with SSRIs
  • Using Clomipramine in youths
  • Guided SSRI dosing
  • What to do when first-line treatment fails: algorithms.
  • Managing Comorbid Disorders with OCD: (a) bipolar disorder, (b) ADHD, & (c) Psychotic Disorders.
  • PANDAS/PANS: overview and treatment,
  • Comments on COVID-19 Impact.
Erica Greenberg, MD

Director, Pediatric Psychiatry OCD and Tic Disorders Program, Massachusetts General Hospital

(3) GERIATRIC PSYCHIATRY: HOARDING DISORDER

Understanding & Managing hoarding disorders in elderly

(Session Duration: 1 hour)

  • Definition, Demographics, Onset, and Course of hoarding disorder in elderly.
  • Comorbid conditions & personality traits in older adults with hoarding disorder.
  • Executive Dysfunction in hoarding disorder.
  • Personal Consequences of hoarding.
  • Treatment of Hoarding Disorder (30 minutes).
Catherine Ayers, PhD

Geropsychologist and Section Chief at the VA San Diego Healthcare System. She is the Chair of the San Diego County Older Adult Council. Her research is focused on the characterization, treatment development, and community intervention implementation for older adults with hoarding disorder.

(4) OBSESSIVE-COMPULSIVE SYMPTOMS IN SCHIZOPHRENIA

Schizo-Obsessive Disorder:
Managing Obsessive-Compulsive Symptoms In Schizophrenia.

(Session Duration: 50 mins)

  • Define the terminology of OCD and schizophrenia and distinguish between delusions and obsessions.
  • Discuss the comorbidity between schizophrenia and OCD including presentation and associated findings.
  • Review the best strategies for the treatment of schizo-obsessive patients.
Robert Hudak, MD

Medical director of the Center for Treatment of Obsessive –Compulsive and Related Disorders at Western Psychiatric Hospital.

(5) PSYCHOTHERAPY: EXPOSURE & RESPONSE PREVENTION FOR OCD TREATMENT

Exposure & Response Prevention:
an inhibitory Learning Approach

WORKSHOP STYLE PRESENTATION (Session Duration: 50 mins)

  • Overview of OCD and its treatment.
  • How does exposure therapy work? Habituation vs. Inhibitory learning
  • Using exposure to foster fear tolerance
  • Techniques for optimizing exposure
    • 1. Expectancy tracking
    • 2. Multi-media exposure
    • 3. Linguistic processing
    • 4. Variability in exposures
      • a) Intensity
      • b) Context
      • c) Practice intervals
  • Response prevention
  • Implications for using cognitive therapy.
  • Implications for ACT
Jonathan S. Abramowitz, Ph.D.

Professor and Clinical Psychologist at the University of North Carolina at Chapel Hill. His book publications include “Understanding and treating obsessive-compulsive disorder”, “Exposure Therapy for Anxiety: Principles and Practice”, and “Getting over OCD”.

(6) OCD TREATMENT DURING COVID-19

Exposure & Response Prevention Treatment during COVID-19

(Session Duration: 30 mins)

  • Not letting uncertainty infect Ethical, effective care
  • How have patients with OCD done during COVID19?
  • Role of telemedicine for ERP implementation during COVID-19
  • Liability concern with ERP during COVID19.
  • Assessment of OCD during COVID19.
  • Challenges for OCD treatment implementation during COVID-19
  • Which patient population with OCD is vulnerable during COVID-19?
Eric Storch, Ph.D.

Professor and McIngvale Presidential Endowed Chair in the Menninger Department
of Psychiatry and Behavioral Sciences at Baylor College of Medicine. He serves as Vice Chair and Head of Psychology, and oversees the CBT for OCD program at BCM. 

(B) NON-ACCREDITED PROGRAM

(7) PERINATAL PSYCHIATRY & OCD

Post-Partum Onset
Obsessive-Compulsive Disorder

Session Duration: 30 mins [not eligible for CME credits]

  • Underlying Biology and Neuroanatomy involved in postpartum onset OCD
  • Case examples: “normal” mom worries, postpartum OCD, or postpartum psychosis.
  • Postpartum mood symptoms & 5 symptoms dimensions of obsessions and compulsions in the postpartum period.
  • Differentiating (a) OCD and postpartum depression; (b) OCD and postpartum Psychosis.
  • Risk assessment of harm to the baby.
  • Postpartum OCD in fathers.
  • Treatment algorithm of (a) postpartum OCD; (b) post-partum Psychosis.
Mary Kimmel, MD

Medical Director of NC Maternal Mental Health MATTERS program, and Co-Director of UNC’s Perinatal Psychiatry Program.

(8) NEUROMODULATION FOR OCD

Deep tMS for Treatment-Resistant OCD

Session Duration: 1 hour [not eligible for CME credits]

  • OCD: Background
  • Deep TMS: Introduction
  • Deep TMS: Treatment Process
  • Deep TMS: Evidence Summary for OCD
  • Treatment of comorbid Depression-OCD with H7 coil.
  • OCD Treatment Guidelines and Medical Society Support.
  • Payers coverage: Current summary.
  • Health economics outcome.
Aron Tendler, MD

Board certified in general psychiatry, obesity medicine and sleep medicine. He is also engaged in clinical research and education on neurostimulation as the Chief Medical Officer for BrainsWay.

CONFERENCE PRICING

(EARLY-BIRD REGISTRATION OPEN NOW)

GENERAL
$ 250
  •  
RESIDENTS & STUDENTS
$ 200
  •  
ACADEMY MEMBERS
$ 100
  •  

DISCOUNTS AVAILABLE FOR: Academy Members, Residents & Students. 

Email us for Discount Code: HSingh@PsychiatryEducationForum.com

CME ACCREDITATIONS

5.25 AMA PRA Category 1 Credits Available

This activity has been planned and implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint
providership of PeerPoint Medical Education Institute and the Psychiatry Education Forum, LLC.
PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical
education for physicians. PeerPoint Medical Education Institute designates the Enduring Material format
for this educational activity for a maximum 5.25 AMA PRA Category 1 Credits™.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

NOTE: CME Credits not available for the following two non-academic program presentations:

  1. Post-Partum Onset Obsessive-Compulsive Disorder: by Dr. Mary Kimmel.
  2. Deep TMS for Treatment-Resistant OCD: by Dr. Aron Tendler.

Accreditation & Designation Statements and Disclosure Report

DISCLAIMER

Please note that this conference is for educational purposes only and do refer to references cited at the end of each presentation for detailed information. Psychiatry Education Forum and author(s) (including our peer-reviewers) of this conference do not assume any liability or responsibility for damage, injury, or death to you, other persons or property from any use of any ideas, information, or instruction in this conference.